Safety and efficacy of trastuzumab emtansine (TDM-1) in a patient on hemodialysis for renal failure
HER2-positive metastatic breast cancer is an aggressive disease with a limited number of treatment options. In the last 15 years, new drugs such as trastuzumab, pertuzumab, lapatinib or trastuzumab emtansine (TDM-1) have sprouted for these patients. There is a huge lack of evidence on the use of som...
| Główni autorzy: | , , , , , |
|---|---|
| Format: | Artykuł |
| Język: | English |
| Wydane: |
Elsevier
2021-01-01
|
| Seria: | Cancer Treatment and Research Communications |
| Hasła przedmiotowe: | |
| Dostęp online: | http://www.sciencedirect.com/science/article/pii/S2468294221000137 |